Table 3.
Number (%) of participants in the two assigned groups by activity and use of HT medication category at baseline and follow-up.
| Variable | Intervention | Control | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 6 months | 12 months | 24 months | Baseline | 6 months | 12 months | 24 months | |
| Leisure physical activity | (n = 240) | (n = 230) | (n = 174) | (n = 156) | (n = 234) | (n = 224) | (n = 184) | (n = 171) |
| Inactive | 152 (63.3) | 64 (27.8) | 36 (20.7) | 45 (28.8) | 148 (63.2) | 126 (56.3) | 102 (55.4) | 88 (51.5) |
| Somewhat active | 39 (16.3) | 47 (20.4) | 30 (17.2) | 30 (19.2) | 21 (9.0) | 41 (18.3) | 29 (15.8) | 31 (18.1) |
| Active | 49 (20.4) | 119 (51.7) | 108 (62.1) | 81 (51.9) | 65 (27.8) | 57 (25.4) | 53 (28.8) | 52 (30.4) |
| Medications for HT | (n = 122) | (n = 115) | (n = 95) | (n = 76) | (n = 103) | (n = 99) | (n = 82) | (n = 82) |
| No medication | 58 (47.5) | 21 (18.3) | 20 (21.1) | 13 (17.1) | 55 (53.4) | 34 (34.3) | 28 (34.1) | 25 (30.5) |
| Non-adherence | 29 (23.8) | 30 (26.1) | 13 (13.7) | 27 (35.5) | 23 (22.3) | 39 (39.4) | 24 (29.3) | 30 (36.6) |
| Adherence | 35 (28.7) | 64 (55.7) | 62 (65.3) | 36 (47.4) | 25 (24.3) | 26 (26.3) | 30 (36.6) | 27 (32.9) |